Related Experiment Video
Updated: Aug 31, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Isolation, Characterization, and Autophagy Function of BECN1-Splicing Isoforms in Cancer Cells
Chinmay Maheshwari1, Chiara Vidoni1, Rossella Titone1
1Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", 13100 Novara, Italy.
Abstract:
Alternative splicing allows the synthesis of different protein variants starting from a single gene. Human Beclin 1 (BECN1) is a key autophagy regulator that acts as haploinsufficient tumor suppressor since its decreased expression correlates with tumorigenesis and poor prognosis in cancer patients. Recent studies show that BECN1 mRNA undergoes alternative splicing. Here, we report on the isolation and molecular and functional characterization of three BECN1 transcript variants (named BECN1-α, -β and -γ) in human cancer cells. In ovarian cancer NIHOVCAR3, these splicing variants were found along with the canonical wild-type. BECN1-α lacks 143 nucleotides at its C-terminus and corresponds to a variant previously described. BECN1-β and -γ lack the BCL2 homology 3 domain and other regions at their C-termini. Following overexpression in breast cancer cells MDA-MB231, we found that BECN1-α stimulates autophagy. Specifically, BECN1-α binds to Parkin and stimulates mitophagy. On the contrary, BECN1-β reduces autophagy with a dominant negative effect over the endogenous wild-type isoform. BECN1-γ maintains its ability to interact with the vacuolar protein sorting 34 and only has a slight effect on autophagy. It is possible that cancer cells utilize the alternative splicing of BECN1 for modulating autophagy and mitophagy in response to environmental stresses.
Insights
Alternative splicing of human Beclin 1 (BECN1) generates variants that modulate autophagy and mitophagy. These BECN1 variants may be key to how cancer cells adapt to stress and influence tumor progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Alternative splicing generates diverse protein variants from a single gene.
- Human Beclin 1 (BECN1) is a crucial autophagy regulator and haploinsufficient tumor suppressor.
- Reduced BECN1 expression is linked to cancer development and poor prognosis.
Purpose of the Study:
- To isolate and characterize novel BECN1 transcript variants in human cancer cells.
- To investigate the functional roles of these BECN1 variants in autophagy and mitophagy.
- To explore the potential implications of BECN1 alternative splicing in cancer progression.
Main Methods:
- Isolation and molecular characterization of BECN1 transcript variants (BECN1-α, -β, -γ).
- Overexpression studies in human breast cancer cells (MDA-MB231).
- Analysis of protein-protein interactions (Parkin, vacuolar protein sorting 34) and autophagy/mitophagy activity.
Main Results:
- Three new BECN1 splicing variants (BECN1-α, -β, -γ) were identified alongside the wild-type.
- BECN1-α stimulates autophagy and mitophagy by interacting with Parkin.
- BECN1-β inhibits autophagy via a dominant-negative effect, while BECN1-γ shows minimal impact.
Conclusions:
- Alternative splicing of BECN1 produces functional variants with opposing roles in autophagy.
- BECN1 variants may allow cancer cells to fine-tune autophagy and mitophagy in response to stress.
- Targeting BECN1 splicing could offer new therapeutic strategies for cancer treatment.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Nucleolus
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Destabilization of Microtubules

